Gadgeel S, Hirsch FR, Kerr K, Barlesi F, et al. Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non-Small Cell Lung Cancer: Results From the Randomized OAK Trial. Clin Lung Cancer 2021 May 30. pii: S1525-7304(21)00101.
PMID: 34226144